( Australia:PXS, OTC-PINK:PXSLY )

News from Pharmaxis Ltd A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages.

Latest

Aug 24, 2017, 20:36 ET Boehringer Ingelheim initiates Phase IIa study of compound acquired from Pharmaxis in debilitating liver disease NASH

- Boehringer Ingelheim commences Phase II program of investigational drug candidate BI 1467335 acquired from Pharmaxis with a 12 week Phase IIa...


Jul 21, 2009, 00:16 ET Pharmaxis Investor Conference Call

Pharmaxis Ltd (ASX: PXS) will release its June 2009 Quarterly Report to Shareholders on the afternoon of Wednesday 22nd July 2009. Dr Alan...


Jul 12, 2009, 19:22 ET Pharmaxis to Voluntarily De-List from Nasdaq

Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced a decision to voluntarily de-list from the Nasdaq Global Market ("Nasdaq"). Pharmaxis has...


Jun 29, 2009, 20:12 ET Pharmaxis Closes Share Purchase Plan

Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced it had raised A$7.2 million from its Share Purchase Plan which closed on 24 June 2009....


Jun 15, 2009, 21:11 ET Phase 3 Cystic Fibrosis Trial Results Presented at European Conference

Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) is pleased to announce that additional results of its recently completed international...


Jun 03, 2009, 20:19 ET Pharmaxis Announces Placement of $47 Million and Share Purchase Plan

Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced that it had raised A$47 million through a placement to Australian and international institutions...


May 13, 2009, 19:33 ET U.S. FDA Accepts Aridol(TM) New Drug Application for Review

Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced it had received notification from the United States Food and Drug Administration (FDA) that the...


May 04, 2009, 04:02 ET Pharmaxis Announces Positive Results of Phase 3 Cystic Fibrosis Trial

Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) is pleased to announce positive results of its recently completed international Phase III...


Apr 06, 2009, 19:02 ET New Pharmaxis Board Appointment

Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of the U.S. life science investment manager Richard van...


Apr 06, 2009, 03:52 ET Pharmaxis Investor Conference Call

Pharmaxis Ltd (AXS: PXS; Nasdaq: PXSL) will release its March 2009 Quarterly Report to Shareholders on the afternoon of Wednesday 8th April 2009....


Mar 31, 2009, 18:58 ET Pharmaxis Announces Milestone in Phase III Trial for Cystic Fibrosis

Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced completion of the first component of its Phase III international trial...


Mar 11, 2009, 02:10 ET Pharmaxis Appoints French Distributor for Aridol(TM)

Pharmaxis (ASX: PXS; NASDAQ: PXSL) is pleased to announce that it has appointed Praxis Pharmaceutical France SARL as its French marketer and...


Jan 27, 2009, 00:51 ET Pharmaxis Investor Conference Call

Pharmaxis Ltd (AXS: PXS, Nasdaq: PXSL) will release its December 2008 Quarterly Report to Shareholders on the afternoon of Wednesday, 28th January...


Sep 30, 2008, 01:00 ET ASX/NASDAQ Media Release: Pharmaxis Files First Marketing Application for Bronchitol in Australia

SYDNEY, Australia, Sept. 30 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that a...


Sep 04, 2008, 01:00 ET Second Pivotal Phase 3 Trial In Cystic Fibrosis Begins

SYDNEY, Australia, Sept. 4 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that it...


Aug 19, 2008, 01:00 ET 12 Month Phase 3 Trial Finds Bronchitol Safe in Bronchiectasis

SYDNEY, Australia, Aug. 20 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the...


Aug 17, 2008, 01:00 ET Bronchitol Phase 3 Cystic Fibrosis Trial Completes Recruitment

SYDNEY, Australia, Aug. 17 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that the first pivotal Phase 3...


Aug 11, 2008, 01:00 ET Bronchitol Cystic Fibrosis Dose Trial Results Positive

SYDNEY, Australia, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- Speciality pharmaceutical company Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced...


Jun 23, 2008, 01:00 ET New Pharmaxis Board Appointment

SYDNEY, Australia, June 23 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of senior...


Jun 16, 2008, 01:00 ET Pharmaxis Establishes Named Patient Program for Bronchitol

SYDNEY, Australia, June 16 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced the appointment of IDIS Limited...


May 18, 2008, 01:00 ET Pharmaxis' Aridol Authorised for Sale in Germany

SYDNEY, Australia, May 18 /Xinhua-PRnewswire-Firstcall/ -- Specialist Pharmaceutical Company Pharmaxis Ltd (ASX: PXS; Nasdaq: PXSL) today...


May 01, 2008, 01:00 ET Regulatory Path for Bronchitol in Bronchiectasis

SYDNEY, Australia, May 1 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (AXS: PSX; Nasdaq: PXSL) today announced that it has agreed with advice from...


Apr 11, 2008, 01:00 ET Pharmaxis Investor Conference Call

SYDNEY, Australia, April 11 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis Ltd (AXS: PSX; Nasdaq: PXSL) will release its March 2008 Quarterly Report...


Mar 27, 2008, 01:00 ET Aridol(TM) Endorsed by International Olympic Committee

SYDNEY, Australia, March 27 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS, Nasdaq: PXSL) today announced that Australian-made Aridol...


Mar 06, 2008, 00:00 ET Pharmaxis' First Steps into China

SYDNEY, Australia, March 6 /Xinhua-PRNewswire-FirstCall/ -- Pharmaxis (ASX: PXS; Nasdaq: PXSL) today announced that a clinical trial application...